<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">Cerebral vasospasm</z:e> remains a major cause of morbidity and mortality in patients with <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="4" ids="30413">Heme</z:chebi> oxygenase-1 (HO-1) is an <z:mp ids='MP_0003674'>oxidative stress</z:mp>-inducible enzyme with multiple protective functions against vascular and <z:e sem="disease" ids="C0027765" disease_type="Disease or Syndrome" abbrv="">neurological diseases</z:e>, including delayed <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>In the present study, intravenous administration (i.v.) of nicaraven (1 mg/kg/min, for 2 days after <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo>) ameliorated delayed <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> in rat <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> models, marked synergistic induction of HO-1 protein (&gt; 2.5-fold than '<z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> with saline i.v.'), and elicited a rapid increase of cGMP accumulation in the basilar arteries </plain></SENT>
<SENT sid="3" pm="."><plain>In the sham-operated rats, nicaraven could not induce HO-1 expression </plain></SENT>
<SENT sid="4" pm="."><plain>Antisense HO-1 oligodeoxynucleotides abrogated this HO-1 induction and the antivasospastic effect of nicaraven </plain></SENT>
<SENT sid="5" pm="."><plain>In vitro study using Hela cells, nicaraven enhanced the human HO-1 promoter (-4.5 kbp) activity, which was pre-activated with the blood component <z:chebi fb="0" ids="7861">oxyhemoglobin</z:chebi> to mimic the ability of <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>These results suggest that this enhanced HO-1 expression through a combination of pathological state and pharmacological agent could be an effective strategy to improve the prognosis of <z:chebi fb="4" ids="30413">heme</z:chebi>- and <z:mp ids='MP_0003674'>oxidative stress</z:mp>-induced diseases, such as delayed <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> </plain></SENT>
</text></document>